tiprankstipranks
Advertisement
Advertisement
NMRA Earnings this Week: How Will it Perform?
PremiumPre-EarningsNMRA Earnings this Week: How Will it Perform?
24d ago
Neumora Therapeutics management to meet virtually with Needham
Premium
The Fly
Neumora Therapeutics management to meet virtually with Needham
1M ago
Neumora upgraded to Outperform from Market Perform at William Blair
Premium
The Fly
Neumora upgraded to Outperform from Market Perform at William Blair
1M ago
Neumora Therapeutics initiated with an Outperform at Leerink
PremiumThe FlyNeumora Therapeutics initiated with an Outperform at Leerink
3M ago
Neumora Therapeutics price target raised to $6 from $5 at Mizuho
Premium
The Fly
Neumora Therapeutics price target raised to $6 from $5 at Mizuho
3M ago
Neumora (NMRA-511): Encouraging Early Alzheimer’s Agitation Data but Mixed V1a History and Valuation Keep Risk-Reward Balanced at Hold
Premium
Ratings
Neumora (NMRA-511): Encouraging Early Alzheimer’s Agitation Data but Mixed V1a History and Valuation Keep Risk-Reward Balanced at Hold
3M ago
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
PremiumThe FlyMidday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
4M ago
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
Premium
The Fly
Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
4M ago
Neumora Issues Shares Following Loan Conversion Notice
Premium
Company Announcements
Neumora Issues Shares Following Loan Conversion Notice
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100